Pet Diabetes Care Devices Market

Starting at US$ 5000

Buy Now
Infographics Companies
Market Size (2026)
USD 2.7 Bn
Forecast (2036)
USD 4.9 Bn
CAGR (2026 to 2036)
6.0%

Pet Diabetes Care Devices Market Size, Market Forecast and Outlook By FMI

The pet diabetes care devices market was valued at USD 2.6 billion in 2025. The market is set to reach USD 2.7 billion by 2026-end and grow at a CAGR of 6.0% between 2026-2036 to reach USD 4.9 billion by 2036. Insulin Delivery Devices will dominate with a 56.0% share, while Cats will lead with a 57.0% share.

Pet Diabetes Care Devices Market Value Analysis
Pet Diabetes Care Devices Market Value Analysis

Key Takeaways, Market Size, and Forecast

  • 2026 Market Size: USD 2.7 Bn
  • 2036 Market Size: USD 4.9 Bn
  • Compound Annual Growth Rate (CAGR): 6.0% from 2026 to 2036
  • Absolute $ Opportunity: USD 2.2 Bn between 2026 and 2036
  • Leading Product Segment: Insulin Delivery Devices
  • Insulin Delivery Devices Share in 2026: 56.0%
  • Fastest-growing Country: USA
  • USA CAGR: 6.4% through 2036

Parameter Details
Market Size in 2026 (Value) USD 2.7 billion
Market Forecast in 2036 (Value) USD 4.9 billion
CAGR (2026 to 2036) 6.0%
Years Considered 2021 to 2036
Base Year 2025
Forecast Period 2026 to 2036
Units Considered Value (USD Bn)
Leading Sub-Region USA

Summary of the Pet Diabetes Care Devices Market

  • Demand and Growth Drivers
    • Rising pet diabetes prevalence, particularly in cats and dogs, is expanding the addressable market for insulin delivery and glucose monitoring devices as pet owners increasingly invest in chronic disease management for companion animals.
    • Insulin delivery devices lead product demand at 56.0%, reflecting the ongoing treatment requirement for diabetic pets that depend on daily or twice-daily insulin administration.
    • Veterinary clinics account for 41.0% of end-user demand, serving as the primary prescribing and initial device dispensing channel for pet diabetes care protocols.
  • Product and Segment View
    • Insulin delivery devices account for 56.0% of product demand, driven by the chronic nature of pet diabetes treatment requiring sustained, repeated device procurement for insulin administration.
    • Dogs lead animal type demand at 52.0%, reflecting the higher diagnosed prevalence of diabetes mellitus in canine populations and established veterinary treatment protocols.
    • Conventional diabetes care devices account for 48.0% of technology demand, with connected and digital monitoring systems emerging in veterinary specialty and home care settings.
  • Geography and Competitive Outlook
    • The USA leads growth at 6.4% through 2036, supported by high pet ownership rates, established veterinary care spending, and FDA-cleared device availability for companion animal diabetes management.
    • Europe and East Asia sustain demand through expanding pet insurance penetration and growing veterinary specialty practice networks that diagnose and treat pet diabetes.
    • Companies with veterinary-specific insulin delivery platforms, glucose monitoring devices, and established veterinary clinic distribution relationships are positioned to capture the expanding chronic pet care market.
  • Analyst Opinion
    • Anurag Sharma, Principal Consultant at FMI says, 'Pet diabetes care device manufacturers that develop affordable, pet-specific glucose monitoring systems and simplify home-use insulin delivery are likely to expand the addressable market as pet owners seek greater treatment convenience.'
    • The pet diabetes care devices market is evolving from a niche veterinary specialty category toward a broader chronic pet care segment as diabetes diagnosis rates increase and treatment compliance expectations rise.
    • Adoption is increasing due to improved veterinary diagnostic capabilities, growing pet owner willingness to invest in chronic disease management, and the expansion of pet insurance programs that cover diabetes treatment devices.
    • Demand is further shaped by the aging pet population, with older cats and dogs exhibiting higher diabetes incidence rates that generate sustained device procurement over multi-year treatment horizons.

Pet Diabetes Care Devices Market Definition

The pet diabetes care devices market covers medical devices designed for the diagnosis, monitoring, and treatment of diabetes mellitus in companion animals, primarily dogs and cats. Products include insulin syringes, insulin pens, glucose monitoring systems, continuous glucose monitors adapted for veterinary use, and diabetes management accessories such as lancets, test strips, and sharps containers.

Pet Diabetes Care Devices Market Inclusions

Market scope covers all commercially traded pet diabetes care devices segmented by product (insulin delivery devices, glucose monitoring devices, diabetes management accessories), animal type (cats, dogs, horses), device (insulin delivery devices, glucose monitoring devices), technology (conventional diabetes care devices, standard monitoring devices, connected diabetes care devices), end user (veterinary clinics, home care settings, veterinary hospitals), and distribution channel (direct sales, distributor sales, online sales). Revenue is tracked from 2026 to 2036.

Pet Diabetes Care Devices Market Exclusions

The scope does not include human diabetes care devices used off-label in veterinary settings without veterinary-specific regulatory clearance, veterinary pharmaceutical products (insulin formulations), or diagnostic laboratory equipment for diabetes testing not used at point of care.

Pet Diabetes Care Devices Market Research Methodology

  • Primary research: FMI analysts interviewed veterinary endocrinologists, veterinary clinic procurement managers, pet diabetes device manufacturers, and pet insurance actuaries in key companion animal care markets.
  • Desk Research: Aggregated data on veterinary device registration, pet insurance claims databases, and companion animal health survey results.
  • Market sizing and forecasting: Bottom-up aggregation of diagnosed pet diabetes prevalence, device requirements for treatment protocols and veterinary clinic purchasing data.
  • Data Validation: Cross-checked quarterly against veterinary device sales data, pet insurance usage data and manufacturer shipment data.

Why is the Pet Diabetes Care Devices Market Growing?

  • The growing incidence of diabetes diagnosis among pets, due to both improved veterinary diagnostic abilities and growing aging pet populations, is increasing the chronic treatment patient pool, which is the source of recurring device procurement demand.
  • The perception of companion animals as family members and the quality of life of the animals justifies the continuous medical investment, which has led to an increase in pet owner spending for management of chronic disease.
  • Higher penetration of pet insurance in North America and Europe is helping to lower the barrier of out-of-pocket costs associated with the purchase of diabetes diagnostic and treatment devices.

The market size of pet diabetes care devices is estimated to be USD 2.7 billion in 2026 and projected to reach USD 4.9 billion by 2036, at a CAGR of 6.0%. The growth is fueled by increasing incidence of diabetes in aging pet populations, rising pet owner spending on chronic disease management, growth in veterinary diagnostic and treatment capabilities in the companion animal care markets.

Dogs are 52.0% of animal type demand and diabetes mellitus is more frequently diagnosed in middle-aged and older dogs. The second largest segment is cats. Feline diabetes involves specific treatment protocols, with glucose monitoring adapted to home care settings needing owner compliance as a critical factor for treatment success.

Direct sales (involving manufacturers and authorized distributors) to veterinary clinics and hospitals constitute 46.0% of sales. Pet owners will purchase replacement supplies (test strips, lancets, syringes) online via veterinary e-commerce platforms and authorized online retailers.

Market Segmentation Analysis

  • Insulin delivery devices account for 58.0%, driven by the chronic need to treat diagnosed diabetic pets with daily insulin administration.
  • The demand for dogs is 57.0% of all animals. Dogs have a higher prevalence of diagnosed diabetes, and there are established veterinary treatment protocols.
  • Veterinary clinics are the main point of diagnosis, prescription and primary device dispensing for pet diabetes care, representing 41.0% of the end-user demand.

The pet diabetes care devices market is segmented on the basis of product, animal type, device, technology, end user and distribution channel. Products include insulin delivery devices, glucose monitoring devices and management accessories. Cats , dogs and horses are animals . End users are veterinary clinics, veterinary hospitals and home care settings.

Insights into the Insulin Delivery Devices Segment

Pet Diabetes Care Devices Market Analysis By Device
Pet Diabetes Care Devices Market Analysis By Device

Insulin Delivery Devices to Account for 58.0% Share of Product Demand in 2026. The chronicity of pet diabetes necessitates daily or bi-daily insulin injections creating a sustained consumable device procurement cycle over the multi-year treatment life span of diagnosed animals.

The standard form of delivery is veterinary-specific insulin syringes with dose markings on a veterinary scale, although insulin pens are becoming more widely used in the home-care setting where ease of use and dose accuracy for the pet owner can reduce barriers to treatment compliance.

Insights into the Dogs Animal Type Segment

Pet Diabetes Care Devices Market Analysis By Animal Type
Pet Diabetes Care Devices Market Analysis By Animal Type

57.0% of demand for animals is for dogs. Diabetes mellitus in dogs is usually diagnosed in dogs between the ages of 7 and 12 years and breed predisposition factors can affect prevalence. The treatment protocols consist of injecting insulin twice daily and periodically monitoring the glucose curves.

Better veterinary diagnostic screening, more routine health checkups and more pet owner awareness of diabetes symptoms has increased diagnosed cases of canine diabetes. For every diagnosed case there is a multi-year flow of device procurement including insulin syringes, glucose monitors, test strips and management accessories.

Pet Diabetes Care Devices Market Drivers, Restraints, and Opportunities

  • The rising rates of diabetes in pets, along with increased investment by pet owners to manage chronic diseases, are expanding the addressable device market with predictable, recurring patterns of procurement.
  • The absence of insurance coverage is a major hurdle for pet owners to adopt the devices, particularly for connected glucose monitoring systems, which have elevated initial and consumable costs.
  • Connected glucose monitoring and data sharing technology adapted from human diabetes care are making remote veterinary monitoring and improved home-care treatment compliance possible.

The pet diabetes care devices market is driven by trends in companion animal health, pet owner spending patterns and veterinary diagnostic capabilities. The increasing prevalence of diabetes and investment for its treatment are expected to drive the growth. However, factors such as device cost sensitivity and vet clinic capacity are expected to hamper the adoption rate.

Rising Pet Diabetes Prevalence

The diagnosed diabetic pet population is expanding due to aging pet populations, increasing pet obesity rates, and improved veterinary diagnostic screening. Each diagnosis creates a multi-year device procurement requirement for treatment that translates into predictable, recurring revenue streams for device manufacturers.

Cost Sensitivity and Insurance Coverage

Then there is the ongoing cost of continuous glucose monitoring devices and insulin delivery systems, which can add up to a significant annual expenditure. Pet owners without insurance coverage may limit the adoption of sophisticated monitoring technology by reducing the frequency of monitoring or delaying upgrades of devices.

Connected Monitoring Technology Adaptation

Human diabetes care has inspired continuous glucose monitoring systems and connected insulin delivery devices that are now being adapted for veterinary use. These technologies allow for remote sharing of data between pet owners and veterinary clinicians, improving treatment compliance and clinical outcomes.

Analysis of Pet Diabetes Care Devices Market By Key Countries

Top Country Growth Comparison Pet Diabetes Care Devices Market Cagr (2026 2036)
Top Country Growth Comparison Pet Diabetes Care Devices Market Cagr (2026 2036)
Country CAGR
USA 6.4%
UK 5.8%
EU 6.0%
Japan 5.6%
South Korea 6.2%
Pet Diabetes Care Devices Market Cagr Analysis By Country
Pet Diabetes Care Devices Market Cagr Analysis By Country
  • The USA is expected to grow at 6.4% through 2036, supported by high pet ownership, existing veterinary expenditure and availability of FDA cleared devices.
  • Strong growth is being seen in South Korea (6.2%) and the EU (6.0%) from expansion of pet insurance and veterinary specialty care infrastructure.
  • The UK (5.8%) and Japan (5.6%) maintain demand through established companion animal care spending and veterinary clinic density.

The global pet diabetes care devices market is projected to expand at 6.0% CAGR from 2026 to 2036. The analysis covers more than 30 countries, with key markets profiled below.

Demand Outlook for Pet Diabetes Care Devices Market in the United States

FDA veterinary device clearance pathways and established CMS-adjacent veterinary reimbursement frameworks provide a regulatory foundation for pet diabetes device commercialization. The US grows at 6.4% through 2036, with high pet ownership, established veterinary spending habits, and growing pet insurance penetration supporting adoption of both conventional and connected diabetes care devices.

  • FDA veterinary device clearance pathways provide regulatory infrastructure for pet-specific insulin delivery and glucose monitoring product launches.
  • Pet insurance penetration growth is reducing out-of-pocket cost barriers for diabetes diagnosis and ongoing device procurement.
  • High veterinary clinic density and established companion animal care spending support rapid device adoption following diabetes diagnosis.

Future Outlook for Pet Diabetes Care Devices Market in the United Kingdom

Demand is shaped by one of the highest pet ownership rates in Europe and established companion animal healthcare spending patterns. The UK grows at 5.8% through 2036, with NHS-adjacent veterinary regulatory frameworks and growing pet insurance coverage supporting chronic pet disease management investment.

  • High pet ownership rates and established veterinary healthcare spending support investment in chronic pet disease management devices.
  • Growing pet insurance penetration is expanding coverage for diabetes treatment devices, reducing the financial barrier to sustained treatment compliance.
  • Updated veterinary regulatory frameworks are establishing quality and safety standards for pet-specific medical devices.

Opportunity Analysis of Pet Diabetes Care Devices Market in the European Union

EU Medical Device Regulation and harmonized veterinary product standards are establishing compliance frameworks that shape pet diabetes device procurement across the single market. The EU grows at 6.0% through 2036, with expanding veterinary specialty practice networks and pet insurance penetration supporting diagnosis rates and treatment device adoption.

  • EU MDR compliance and harmonized veterinary device standards create a unified regulatory framework for pet diabetes care device commercialization.
  • Expanding veterinary specialty practice networks are increasing diabetes diagnosis rates through improved screening and endocrinology referral capabilities.
  • Pet insurance growth across EU member states is reducing financial barriers to chronic pet disease treatment and device procurement.

In-depth Analysis of Pet Diabetes Care Devices Market in Japan

Domestic medical device manufacturers with established veterinary product lines are positioning to serve the growing pet diabetes care segment. Japan grows at 5.6% through 2036, with PMDA regulatory oversight, long device qualification cycles, and aging pet populations supporting steady growth in insulin delivery and glucose monitoring device procurement.

  • PMDA regulatory frameworks establish quality and safety standards for veterinary medical devices, including pet diabetes care products.
  • Long qualification cycles and strict compliance requirements favor established domestic device manufacturers with veterinary regulatory experience.
  • Aging pet populations with increasing diabetes incidence are generating multi-year treatment device procurement requirements.

Sales Analysis of Pet Diabetes Care Devices Market in South Korea

Expanding veterinary hospital networks and growing pet healthcare spending are creating distribution infrastructure for pet diabetes care devices. South Korea grows at 6.2% through 2036, with government R&D support for veterinary medical devices and MFDS regulatory oversight establishing compliance pathways for domestic and imported pet care products.

  • Government R&D support for veterinary medical device development is accelerating domestic capability in pet diabetes monitoring technology.
  • MFDS regulatory standards establish compliance requirements for pet diabetes care device registration and distribution.
  • Expanding veterinary hospital networks and increasing pet healthcare expenditure create growing distribution channels for diabetes care devices.

Competitive Landscape and Strategic Positioning

Pet Diabetes Care Devices Market Analysis By Company
Pet Diabetes Care Devices Market Analysis By Company
  • Zoetis Inc. leads through veterinary pharmaceutical and diagnostic infrastructure that extends into diabetes management device distribution and clinical support.
  • Trividia Health (PetTest) and Merck Animal Health compete on device specificity for veterinary use, glucose monitoring accuracy, and veterinary clinic distribution relationships.
  • Competitive advantage depends on veterinary regulatory clearance, device accuracy for animal glucose ranges, and the ability to integrate devices into established veterinary treatment protocols.

Zoetis Inc. holds a leading position through its broad veterinary pharmaceutical and diagnostic portfolio, which provides established veterinary clinic relationships and distribution infrastructure for diabetes care device placement. The company leverages its veterinary clinical support capabilities to drive device adoption.

Trividia Health, Inc. (PetTest brand) offers pet-specific glucose monitoring systems calibrated for animal blood glucose ranges, competing on device accuracy and ease of use for home care settings. Merck Animal Health provides veterinary insulin and associated delivery devices through its established animal health distribution network.

Barriers to entry include veterinary regulatory clearance requirements, the need for device calibration to animal-specific glucose ranges, established veterinary clinic distribution relationships, and the clinical validation requirements that veterinary endocrinologists demand before recommending new devices for patient care protocols.

Key Companies in the Pet Diabetes Care Devices Market

Key global companies leading the pet diabetes care devices market include:

  • Zoetis Inc. (USA) and Merck Animal Health (USA) lead with broad veterinary product portfolios, established clinic distribution, and clinical support infrastructure that extends into diabetes care device placement.
  • Trividia Health, Inc. (USA) and UltiMed, Inc. (USA) offer pet-specific glucose monitoring and insulin delivery devices designed for veterinary and home care applications.
  • i-SENS, Inc. (South Korea) and emerging veterinary medtech startups are developing connected glucose monitoring solutions adapted from human diabetes care technology for veterinary applications.

Competitive Benchmarking: Pet Diabetes Care Devices Market

Company Device Range Veterinary Access Technology Geographic Reach
Zoetis Inc. Broad Strong High Global
Trividia Health, Inc. (PetTest) Broad Strong High Global
Merck Animal Health Moderate Moderate High Regional
UltiMed, Inc. Moderate Moderate Medium Regional
i-SENS, Inc. Moderate Moderate Medium Regional

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Pet Diabetes Care Devices Market

  • In 2025, Zoetis Inc. continued strengthening its companion animal diabetes care portfolio through veterinary diagnostics support and integrated disease management solutions, helping veterinarians improve monitoring and treatment of diabetic pets.
  • In 2025, the pet diabetes care devices market continued to evolve with increasing adoption of at-home glucose monitoring technologies adapted from human medical devices, supporting improved long-term diabetes management in cats and dogs.

Key Players in the Pet Diabetes Care Devices Market

Major Global Players

  • Zoetis Inc.
  • Trividia Health, Inc. (PetTest)
  • Merck Animal Health
  • UltiMed, Inc.
  • i-SENS, Inc.

Emerging Players/Startups

  • PetPace
  • VetMedWearables
  • Biotangents
  • VetMedWearables (Germany)
  • PetPace (Israel)

Report Scope and Coverage

Pet Diabetes Care Devices Market Breakdown By Product, Animal Type, And Region
Pet Diabetes Care Devices Market Breakdown By Product, Animal Type, And Region
Parameter Details
Market size by 2036 USD 4.9 billion
Growth rate 6.0% CAGR (2026 to 2036)
Forecast period 2026 to 2036
Base year value (2025) USD 2.6 billion
Key Segment Covered Product, Animal Type, Device, Technology, End User, Distribution Channel
Regions covered North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered USA, UK, EU, Japan, South Korea, 30 plus countries
Key companies profiled Zoetis Inc., Trividia Health, Inc. (PetTest), Merck Animal Health, UltiMed, Inc., i-SENS, Inc.
Approach Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Market Segmentation Analysis

Pet Diabetes Care Devices Market Segmented by Product:

  • Insulin Delivery Devices
    • Insulin Delivery Pens
      • Reusable Insulin Pens
      • Disposable Insulin Pens
    • Insulin Syringes
      • U 40 Insulin Syringes
      • U 100 Insulin Syringes
  • Glucose Monitoring Devices
    • Blood Glucose Meters
      • Portable Glucose Meters
      • Bluetooth Enabled Glucose Meters
    • Continuous Glucose Monitoring Devices
      • Wearable Monitoring Devices
      • Real Time Monitoring Systems
  • Diabetes Management Accessories
    • Test Strips
      • Single Use Test Strips
      • Multi Pack Test Strips
    • Lancets And Needles
      • Safety Lancets
      • Fine Gauge Needles

Pet Diabetes Care Devices Market Segmented by Animal Type:

  • Cats
    • Indoor Cats
      • Senior Cats
      • Obese Cats
  • Outdoor Cats
    • Active Cats
    • Mixed Breed Cats
  • Dogs
    • Small Breed Dogs
      • Toy Breeds
      • Companion Breeds
    • Large Breed Dogs
      • Working Breeds
      • Sporting Breeds
  • Horses
    • Performance Horses
      • Racing Horses
      • Show Horses
    • Recreational Horses
      • Farm Horses
      • Companion Horses

Pet Diabetes Care Devices Market Segmented by Device:

  • Insulin Delivery Devices
    • Insulin Delivery Pens
      • Reusable Pens
      • Disposable Pens
    • Insulin Syringes
      • Manual Syringes
      • Safety Syringes
  • Glucose Monitoring Devices
    • Blood Glucose Monitoring Devices
      • Handheld Monitors
      • Digital Monitors
    • Continuous Glucose Monitoring Devices
      • Wearable Sensors
      • Smart Monitoring Systems

Pet Diabetes Care Devices Market Segmented by Technology:

  • Conventional Diabetes Care Devices
    • Manual Insulin Administration
      • Traditional Syringes
      • Basic Insulin Pens
  • Standard Monitoring Devices
    • Strip Based Monitoring
    • Portable Glucose Readers
  • Connected Diabetes Care Devices
    • Bluetooth Enabled Devices
      • Smartphone Connected Monitors
      • Cloud Connected Systems
    • Continuous Monitoring Systems
      • Wearable Sensors
      • Real Time Monitoring Devices

Pet Diabetes Care Devices Market Segmented by End User:

  • Veterinary Clinics
    • Private Veterinary Clinics
      • Routine Diabetes Care
      • Outpatient Monitoring
    • Specialty Diabetes Clinics
      • Advanced Diabetes Management
      • Long Term Monitoring
  • Home Care Settings
    • Pet Owner Managed Care
      • Daily Insulin Administration
      • Routine Glucose Monitoring
    • Remote Monitoring Setups
      • Connected Diabetes Devices
      • Tele Veterinary Support
  • Veterinary Hospitals
    • General Veterinary Hospitals
      • Emergency Diabetes Care
      • Inpatient Monitoring
    • Specialized Animal Hospitals
      • Advanced Diabetes Treatment
      • Critical Care Monitoring

Pet Diabetes Care Devices Market Segmented by Distribution Channel:

  • Direct Sales
    • Veterinary Supply Contracts
      • Hospital Procurement
      • Clinic Procurement
  • Distributor Sales
    • Medical Device Distributors
      • Regional Distribution Networks
      • Wholesale Veterinary Suppliers
  • Online Sales
    • E Commerce Platforms
      • Direct Brand Websites
      • Third Party Online Retailers

Pet Diabetes Care Devices Market Segmented by Pricing Tier:

  • Economy Diabetes Care Devices
    • Basic Monitoring Devices
      • Standard Syringes
      • Basic Glucose Meters
  • Mid Range Diabetes Care Devices
    • Connected Monitoring Devices
      • Bluetooth Enabled Devices
      • Reusable Insulin Pens
  • Premium Diabetes Care Devices
    • Advanced Monitoring Systems
      • Continuous Glucose Monitoring Devices
      • Smart Diabetes Management Systems

Pet Diabetes Care Devices Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Türkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • 1. American Veterinary Medical Association. (2025). AVMA Guidelines on Companion Animal Diabetes Diagnosis and Management. AVMA.
  • 2. USA Food and Drug Administration. (2025). FDA Center for Veterinary Medicine: Veterinary Device Regulation Framework. FDA.
  • 3. World Small Animal Veterinary Association. (2025). WSAVA Global Nutrition Guidelines: Pet Diabetes and Metabolic Disease Management. WSAVA.
  • 4. European Medicines Agency. (2025). EMA Veterinary Medicinal Products Committee: Medical Device Standards for Companion Animals. EMA.
  • 5. North American Pet Health Insurance Association. (2025). NAPHIA State of the Industry Report: Pet Insurance Utilization and Chronic Disease Coverage. NAPHIA.

This bibliography is provided for reader reference.

This Report Answers

  • Estimating the size of the market and projected revenue from 2026 to 2036.
  • Segmentation by product, animal type, device, technology, end user, distribution channel.
  • Insights covering more than 30 country markets.
  • Analysis of device categories including insulin delivery devices, glucose monitoring devices, and diabetes management accessories.
  • Assessment of the competitive landscape and strategic positioning.
  • Identification of growth opportunities in pet diabetes diagnosis, connected monitoring technology, and home care device adoption.
  • Tracking veterinary regulatory frameworks and pet insurance coverage expansion across key markets.
  • Delivery of data in PDF and Excel formats.

Frequently Asked Questions

How big is the pet diabetes care devices market in 2026?

The global pet diabetes care devices market is estimated to be valued at USD 2.7 billion in 2026.

What will be the size of the pet diabetes care devices market in 2036?

The market size for the pet diabetes care devices market is projected to reach USD 4.9 billion by 2036.

How much will the pet diabetes care devices market grow between 2026 and 2036?

The pet diabetes care devices market is expected to grow at a 6.0% CAGR between 2026 and 2036.

What are the key products in the pet diabetes care devices market?

The key products in the pet diabetes care devices market are Insulin Delivery Devices, Glucose Monitoring Devices and Diabetes Management Accessories.

Which animal type segment is expected to contribute a significant share in the pet diabetes care devices market in 2026?

In terms of animal type, the cats segment is expected to command 57.0% share in the pet diabetes care devices market in 2026.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Pet Diabetes Care Devices Market